PET of glial metabolism using 2-18F-fluoroacetate

Journal of Nuclear Medicine

Volumn 50, Issue 6, 2009, Pages 982-990

  Marik, Jan ^a   Ogasawara, Annie ^a   Martin McNulty, Baby ^a   Ross, Jed ^a   Flores, Judith E ^a   Gill, Herman S ^a   Tinianow, Jeffn ^a   Vanderbilt, Alexander N ^a   Nishimura, Merry ^a   Peale, Franklin ^a   Pastuskovas, Cinthia ^a   Greve, Joan M ^a   Van Bruggen, Nicholas ^a   Williams, Simon P ^a  

^a GENENTECH INC   (United States)

Author keywords

2 18F fluoroacetate; Glial metabolism; Glioblastoma; Ischemiahypoxia; PET; Stroke

Indexed keywords

2 FLUOROACETATE F 18; FLUORINE 18; FLUOROACETIC ACID; FLUORODEOXYGLUCOSE F 18; TRACER; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACCUMULATION; DRUG UPTAKE; GLIA CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; INFLAMMATION; ISOTOPE LABELING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; TUMOR XENOGRAFT;

ANIMALS; BRAIN ISCHEMIA; FLUORINE RADIOISOTOPES; FLUOROACETATES; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HYPOXIA-ISCHEMIA, BRAIN; MALE; MICE; MICE, INBRED C57BL; NEUROGLIA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR;

EID: 66649107242     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.057356     Document Type: Article

References (39)

1. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease: a doubleedged sword. Neuron. 2002;35:419-432.
2. Banati RB. Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain. Br Med Bull. 2003;65:121-131. (Pubitemid 36406461)
3. 3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab. 1991;11:314-322.
4. 3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci Lett. 1991;133:20-24.
5. Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol. 2006;80:308-322. (Pubitemid 46107737)
6. 11C]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008;35:2304-2319.
7. 11C]octanoate as a PET tracer of glial functions. Nucl Med Biol. 2002;29:303-306.
8. 123I-iomazenil. J Nucl Med. 2003;44:1168-1175.
9. Muir D, Berl S, Clarke DD. Acetate and fluoroacetate as possible markers for glial metabolism in vivo. Brain Res. 1986;380:336-340. (Pubitemid 16015552)
10. 14C]acetate. J Nucl Med. 2001;42:1243-1250.
11. 11C-acetate. Eur J Nucl Med Mol Imaging. 2006;33:420-427.
12. 18F-FDG PET. Nucl Med Biol. 2008;35:171-176.
13. Fonnum F, Johnsen A, Hassel B. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia. 1997;21:106-113 (Pubitemid 27389646)
14. Lear JL, Ackermann RF. Evaluation of radiolabeled acetate and fluoroacetate as potential tracers of cerebral oxidative metabolism. Metab Brain Dis. 1990;5:45-56. (Pubitemid 20251344)
15. Clarke DD. Fluoroacetate and fluorocitrate: mechanism of action. Neurochem Res. 1991;16:1055-1058.
16. Peters R, Wakelin RW. Biochemistry of fluoroacetate poisoning; the isolation and some properties of the fluorotricarboxylic acid inhibitor of citrate metabolism. Proc R Soc Lond B Biol Sci. 1953;140:497-507.
17. Morrison JF, Peters RA. Biochemistry of fluoroacetate poisoning: the effect of fluorocitrate on purified aconitase. Biochem J. 1954;58:473-479.
18. Lauble H, Kennedy MC, Emptage MH, Beinert H, Stout CD. The reaction of fluorocitrate with aconitase and the crystal structure of the enzyme-inhibitor complex. Proc Natl Acad Sci USA. 1996;93:13699-13703. (Pubitemid 26424182)
19. Lloyd SJ, Lauble H, Prasad GS, Stout CD. The mechanism of aconitase: 1.8 A resolution crystal structure of the S642a:citrate complex. Protein Sci. 1999;8:2655-2662. (Pubitemid 30007627)
20. Padgett HC, Schmidt DG, Luxen A, Bida GT, Satymurthy N, Barrio JR. Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. Int J Rad Appl Instrum [A]. 1989;40:433-445. (Pubitemid 19153716)
21. 18F]fluoroacetate: a simple and fast method using a commercial synthesizer. Nucl Med Biol. 2006;33:153-158.
22. 11C-acetate. J Nucl Med. 2007;48:420-428.
23. 18F-fluoroacetate using PET/CT. Eur J Nucl Med Mol Imaging. 2004;31:797.
24. Waniewski RA, Martin DL. Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci. 1998;18:5225-5233. (Pubitemid 28311939)
25. 18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205-212.
26. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture: neurological and pathological evaluation of an improved model. Stroke. 1996;27:1616-1622 (Pubitemid 26295914)
27. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema: I. A new experimental model of cerebral embolism in rats in which recirculation can be introduced into the ischemic area. Jpn J Stroke. 1986;8:1-8.
28. Adhami F, Liao G, Morozov YM, et al. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol. 2006;169:566-583. (Pubitemid 44156315)
29. Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx. 2005;2:396-409. (Pubitemid 41444874)
30. Hossmann KA. Experimental models for the investigation of brain ischemia. Cardiovasc Res. 1998;39:106-120. (Pubitemid 28322383)
31. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med. 2000;27:542-549.
32. Douglas JG, Stelzer KJ, Mankoff DA, et al. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2006;64:886-891. (Pubitemid 43183589)
33. 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. J Nucl Med. 2002;43:1667-1673.
34. Anderson MF, Blomstrand F, Blomstrand C, Eriksson PS, Nilsson M. Astrocytes and stroke: networking for survival? Neurochem Res. 2003;28:293-305.
35. Denes A, Vidyasagar R, Feng J, et al. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab. 2007;27:1941-1953. (Pubitemid 350129163)
36. 11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett. 2007;411:200-205.
37. Williams AJ, Hale SL, Moffett JR, et al. Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factorkappaB activation, gliosis, and leukocyte infiltration. J Cereb Blood Flow Metab. 2003;23:75-87. (Pubitemid 36015096)
38. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91. (Pubitemid 19040218)
39. Tecle B, Casida JE. Enzymatic defluorination and metabolism of fluoroacetate, fluoroacetamide, fluoroethanol, and (-)-erythro-fluorocitrate in rats and mice examined by 19F and 13C NMR. Chem Res Toxicol. 1989;2:429-435 (Pubitemid 20048265)